These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31783142)

  • 1. Determinants of aspirin resistance in patients with type 2 diabetes.
    Paven E; Dillinger JG; Bal Dit Sollier C; Vidal-Trecan T; Berge N; Dautry R; Gautier JF; Drouet L; Riveline JP; Henry P
    Diabetes Metab; 2020 Oct; 46(5):370-376. PubMed ID: 31783142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease.
    Larsen SB; Grove EL; Kristensen SD; Hvas AM
    Thromb Haemost; 2013 May; 109(5):920-9. PubMed ID: 23407706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between insulin receptor substrate-1 polymorphisms and high platelet reactivity with clopidogrel therapy in coronary artery disease patients with type 2 diabetes mellitus.
    Zhang D; Zhang X; Liu D; Liu T; Cai W; Yan C; Han Y
    Cardiovasc Diabetol; 2016 Mar; 15():50. PubMed ID: 27005817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease.
    Grove EL; Hvas AM; Mortensen SB; Larsen SB; Kristensen SD
    J Thromb Haemost; 2011 Jan; 9(1):185-91. PubMed ID: 20955349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
    Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
    Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calprotectin and platelet aggregation in patients with stable coronary artery disease.
    Larsen SB; Grove EL; Pareek M; Kristensen SD; Hvas AM
    PLoS One; 2015; 10(5):e0125992. PubMed ID: 25970343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High platelet reactivity on aspirin in patients with acute ST elevation myocardial infarction.
    Dillinger JG; Saeed A; Spagnoli V; Sollier CB; Sideris G; Silberman SM; Voicu S; Drouet L; Henry P
    Thromb Res; 2016 Aug; 144():56-61. PubMed ID: 27289074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
    Angiolillo DJ; Bernardo E; Sabaté M; Jimenez-Quevedo P; Costa MA; Palazuelos J; Hernández-Antolin R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Guzman LA; Bass TA; Macaya C; Fernandez-Ortiz A
    J Am Coll Cardiol; 2007 Oct; 50(16):1541-7. PubMed ID: 17936152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between urinary 11-dehydrothromboxane B2 detection and platelet Light Transmission Aggregometry (LTA) assays for evaluating aspirin response in elderly patients with coronary artery disease.
    Liu T; Zhang J; Chen X; Feng X; Fu SW; McCaffrey TA; Liu M
    Gene; 2015 Oct; 571(1):23-7. PubMed ID: 26095809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of reduced antiplatelet effect of aspirin in patients with stable coronary artery disease.
    Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
    PLoS One; 2015; 10(5):e0126767. PubMed ID: 25993271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced antiplatelet effect of aspirin during 24 hours in patients with coronary artery disease and type 2 diabetes.
    Christensen KH; Grove EL; Würtz M; Kristensen SD; Hvas AM
    Platelets; 2015; 26(3):230-5. PubMed ID: 24750015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of high on-aspirin platelet reactivity in high-risk vascular patients treated with single or dual antiplatelet therapy.
    Amsallem M; Manzo-Silberman S; Dillinger JG; Sideris G; Voicu S; Bal dit Sollier C; Drouet L; Henry P
    Am J Cardiol; 2015 May; 115(9):1305-10. PubMed ID: 25759104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ASA dose doubling versus switching to clopidogrel on plasma inflammatory markers concentration in patients with type 2 diabetes and high platelet reactivity: the AVOCADO study.
    Rosiak M; Postula M; Kaplon-Cieslicka A; Kondracka A; Trzepla E; Czlonkowski A; Janicki PK; Filipiak KJ; Opolski G
    Cardiol J; 2013; 20(5):545-51. PubMed ID: 24469880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease.
    Henry P; Vermillet A; Boval B; Guyetand C; Petroni T; Dillinger JG; Sideris G; Bal dit Sollier C; Drouet L
    Thromb Haemost; 2011 Feb; 105(2):336-44. PubMed ID: 21136023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study.
    Kuliczkowski W; Radomski M; Gąsior M; Urbaniak J; Kaczmarski J; Mysiak A; Negrusz-Kawecka M; Bil-Lula I
    Biomed Res Int; 2017; 2017():9352015. PubMed ID: 28770228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential impact of inflammation on six laboratory assays measuring residual arachidonic acid-inducible platelet reactivity during dual antiplatelet therapy.
    Gremmel T; Perkmann T; Seidinger D; Koppensteiner R; Panzer S; Kopp CW; Steiner S
    J Atheroscler Thromb; 2013; 20(7):630-45. PubMed ID: 23739624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of polymorphism and type II diabetes on aspirin resistance in patients with unstable coronary artery disease.
    Gao F; Wang ZX; Men JL; Ren J; Wei MX
    Chin Med J (Engl); 2011 Jun; 124(11):1731-4. PubMed ID: 21740787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment.
    Temperilli F; Rina A; Massimi I; Montemari AL; Guarino ML; Zicari A; Pulcinelli FM
    Platelets; 2015; 26(8):783-7. PubMed ID: 25734355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of plasma concentrations of salicylic acid and high on ASA platelet reactivity in type 2 diabetes patients.
    Postula M; Janicki PK; Rosiak M; Przybylkowski A; Kaplon-Cieslicka A; Grygorowicz T; Trzepla E; Filipiak KJ; Czlonkowski A; Opolski G
    Cardiol J; 2013; 20(2):170-7. PubMed ID: 23558875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.